• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

    11/22/23 7:58:06 AM ET
    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Professional Services
    Consumer Discretionary
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $AGIL alert in real time by email

    Shares of Guess?, Inc. (NYSE:GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance below estimates.

    Guess? reported quarterly earnings of 49 cents per share, down from the analyst consensus estimate of 62 cents per share, according to data from Benzinga Pro. The company reported quarterly sales of $651.00 million, missing market expectations of $656.03 million.

    The company lowered its full-year 2024 outlook, expecting revenue growth between 1.8% and 2.4% and adjusted earnings per share between $2.67 and $2.74.

    Guess shares fell 15.2% to $20.11 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • AgileThought, Inc. (NASDAQ:AGIL) shares rose 96.2% to $0.1628 in pre-market trading after gaining 5% on Tuesday.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares surged 47% to $0.2426 in pre-market trading after falling 23% on Tuesday.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares rose 34% to $0.27 in pre-market trading. HeartSciences recently announced closing of license agreements with the Icahn School of Medicine at Mount Sinai to develop and commercialize AI cardiovascular algorithms.
    • Vicinity Motor Corp. (NASDAQ:VEV) rose 19.2% to $1.00 in pre-market trading. Vicinity Motor recently posted downbeat quarterly results.
    • Connect Biopharma Holdings Limited(NASDAQ:CNTB) gained 18.3% to $1.49 in pre-market trading after dipping over 40% on Tuesday. Connect Biopharma Holdings released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy and safety in patients with moderate-to-severe atopic dermatitis (AD).
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares climbed 17.3% to $0.3180 in pre-market trading after falling 7% on Tuesday.
    • Captivision Inc. (NASDAQ:CAPT) shares rose 15.8% to $1.69 in pre-market trading after gaining around 10% on Tuesday.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) rose 12.8% to $0.70 in pre-market trading after gaining around 7% on Tuesday.
    • Sigma Additive Solutions, Inc. (NASDAQ:SASI) rose 11.9% to $3.38 in pre-market trading. The company recently posted a quarterly loss of $1.57 per share.
    • Safe and Green Development Corporation (NASDAQ:SGD) gained 11.4% to $4.20 in pre-market trading. Safe and Green Development shares jumped 33% on Tuesday after the company signed a non-binding Letter of Intent to invest money in Majestic World Holdings in exchange for access to the software platform Xene.

    Losers

    • Nogin, Inc. (NASDAQ:NOGN) dipped 20.8% to $0.2994 in pre-market trading after jumping 21% on Tuesday.
    • Emeren Group Ltd (NYSE:SOL) shares fell 18.7% to $2.13 in pre-market trading after posting a loss for the third quarter.
    • UpHealth, Inc. (NYSE:UPH) shares fell 16.6% to $0.6601 in pre-market trading after falling around 19% on Tuesday.
    • The Beachbody Company, Inc. (NYSE:BODY) shares fell 16.2% to $6.28 in pre-market trading. The Beachbody Company completed a 1-for-50 reverse stock split.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 15.7% to $0.3350 in pre-market after declining 6% on Tuesday.
    • Alterity Therapeutics Limited (NASDAQ:ATHE) fell 14.8% to $2.02 in pre-market trading.
    • Anghami Inc. (NASDAQ:ANGH) fell 14.2% to $2.67 in pre-market trading. Anghami shares jumped 97% on Tuesday after the company and OSN+ announced a deal that will combine their businesses.
    • DLocal Limited (NASDAQ:DLO) shares fell 12.9% to $16.38 in pre-market trading after the company reported downbeat third-quarter financial results and reaffirmed FY23 revenue guidance below estimates.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares fell 8.2% to $0.1992 in pre-market trading after jumping 25% on Tuesday.

     

    Now Read This: Deere, Nvidia And 3 Stocks To Watch Heading Into Wednesday

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ANGH
    $ATHE
    $BNRG

    CompanyDatePrice TargetRatingAnalyst
    DLocal Limited
    $DLO
    12/17/2025$21.00Outperform
    Itau BBA
    DLocal Limited
    $DLO
    12/11/2025$16.00Hold → Buy
    Truist
    Connect Biopharma Holdings Limited
    $CNTB
    12/1/2025$9.00Buy
    Lake Street
    Connect Biopharma Holdings Limited
    $CNTB
    10/31/2025$10.00Buy
    BTIG Research
    DLocal Limited
    $DLO
    10/14/2025$19.00Neutral → Buy
    Goldman
    Guess? Inc.
    $GES
    8/21/2025$13.00 → $16.75Market Perform
    Telsey Advisory Group
    DLocal Limited
    $DLO
    8/14/2025$15.00Hold → Buy
    HSBC Securities
    Connect Biopharma Holdings Limited
    $CNTB
    6/12/2025$7.00Buy
    H.C. Wainwright
    More analyst ratings

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    SEC Filings

    View All

    SEC Form 6-K filed by Alterity Therapeutics Limited

    6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer)

    3/9/26 8:00:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form PRE 14A filed by HeartSciences Inc.

    PRE 14A - HeartSciences Inc. (0001468492) (Filer)

    3/6/26 5:13:19 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    3/6/26 7:43:59 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Yorke Justin W bought $9,889 worth of shares (12,400 units at $0.80) (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    1/31/25 5:06:27 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Ng George K bought $69,542 worth of shares (87,200 units at $0.80) (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    1/29/25 5:05:00 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pres. Research & Development Young David bought $99,289 worth of shares (124,500 units at $0.80), increasing direct ownership by 154% to 205,405 units (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    1/29/25 4:24:39 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting

    SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that the results of a Phase 3 study of rademikibart in moderate-to-severe atopic dermatitis (AD) conducted by the Company's partner in China, Simcere Pharmaceutical Co., Ltd. (Simcere), will be presented in the Late-Breaking Research session at the 2026 AAD Annual Meeting, which takes place March 27-31, 2026, in Denver, Colorado. "We are very encouraged by the acceptance of our partner's Phase 3 atopic dermatitis study f

    3/10/26 9:00:00 AM ET
    $CNTB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    As European Gas Prices Double, Brenmiller Energy Accelerates Clean Heat Strategy

    Brenmiller accelerates BNRG360 platform to deliver bundled power and heat to industrial customers, in response to fossil fuel market volatilityTel Aviv, Israel--(Newsfile Corp. - March 10, 2026) - Brenmiller Energy Ltd. (NASDAQ:BNRG) ("Brenmiller", "Brenmiller Energy" or the "Company"), a leading provider of thermal energy storage ("TES") solutions for industrial and utility applications, today announced the acceleration of its BNRG360 platform to deliver bundled power and heat to industrial customers.European natural gas prices have surged past €60 per megawatt-hour, more than doubling in two weeks as the Middle East conflict disrupts global energy supply routes. With Qatar's largest LNG ex

    3/10/26 8:07:00 AM ET
    $BNRG
    Building Products
    Industrials

    Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit

    MELBOURNE, Australia and SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced  that David Stamler, M.D., Chief Executive Officer of Alterity, will participate in the Bell Potter Healthcare Horizons Summit taking place 12-13 March 2026 in Sorrento, Australia. At the conference, Dr. Stamler will participate in a fireside chat entitled, "Optimising Late-stage Clinical Trials to Increase the Odds," and will also host 1-on-1 investor meetings. About Alterity Therapeutics Limited  Alterity Therap

    3/9/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Itau BBA initiated coverage on dLocal Limited with a new price target

    Itau BBA initiated coverage of dLocal Limited with a rating of Outperform and set a new price target of $21.00

    12/17/25 9:18:01 AM ET
    $DLO
    Real Estate

    dLocal Limited upgraded by Truist with a new price target

    Truist upgraded dLocal Limited from Hold to Buy and set a new price target of $16.00

    12/11/25 8:44:49 AM ET
    $DLO
    Real Estate

    Lake Street initiated coverage on Connect Biopharma with a new price target

    Lake Street initiated coverage of Connect Biopharma with a rating of Buy and set a new price target of $9.00

    12/1/25 9:37:24 AM ET
    $CNTB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Campbell Kerry G.

    4 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Issuer)

    3/11/26 7:31:29 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 3 filed by new insider Magnetar Financial Llc

    3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Issuer)

    3/2/26 5:23:17 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Pres. Research & Development Young David converted options into 49 shares, increasing direct ownership by 0.56% to 8,752 units (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    2/4/26 5:09:36 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Leadership Updates

    Live Leadership Updates

    View All

    Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

    MELBOURNE, Australia and SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that Daniel O. Claassen, M.D., M.S., was appointed Chief Medical Advisor and will begin his role in March 2026. As a tenured professor, Dr. Claassen will also retain his academic appointment at Vanderbilt University Medical Center. Dr. Claassen is a board-certified neurologist and internationally recognized expert in neurodegenerative diseases, with more than two decades of clinical and translational research in mov

    3/4/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

    − Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced − Highlights Phase 2 data for ATH434 in Multiple System Atrophy (MSA) strengthened by additional analyses and multiple international scientific presentations during the quarter.Regulatory planning activities advancing toward a pivotal Phase 3 program, including preparation for FDA End-Of-Phase-2 meeting in mid-2026.Ongoing partnering and strategic discussions with pharmaceutical companies and corporate advisers to explore non-dilutive pathways to fund Phase 3 development.Board and executive leadership strengthened to support Alterity through its next stage of clinical development, partnering and comme

    1/30/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Winmark Set to Join S&P SmallCap 600

    NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Winmark Corp. (NASD: WINA) will replace Guess? Inc. (NYSE:GES) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, January 26. Authentic Brands Group LLC and the Rolling Stockholders are acquiring Guess? in a deal expected to close soon pending final closing conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Jan 26, 2026 S&P SmallCap 600 Addition Winmark WINA Consumer Discretionary Jan 26, 2026 S&P SmallCap 600 Deletion Guess? GES Consumer Discretionary ABOUT S&P DOW JONES INDICES S&P Dow Jone

    1/21/26 6:01:00 PM ET
    $GES
    $SPGI
    $WINA
    Apparel
    Consumer Discretionary
    Finance: Consumer Services
    Finance

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    $AGIL
    $ANGH
    $ATHE
    $BNRG
    Financials

    Live finance-specific insights

    View All

    dLocal to Report Fourth Quarter 2025 Financial Results

    MONTEVIDEO, Uruguay, Jan. 26, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ:DLO, "dLocal" or the "Company")), a leading financial technology company powering payments across emerging markets, intends to release financial results for its fourth fiscal quarter ended December 31, 2025 on March 18, 2026 after market close. The Company will host a conference call and video webcast on March 18, 2026 at 5:00 p.m. Eastern Time. Please click here to pre-register for the conference call and obtain your dial in number and passcode. The live conference call can be also accessed via audio webcast at the investor relations section of the Company's website, at https://investor.dlocal.com/. An archive

    1/26/26 4:35:00 PM ET
    $DLO
    Real Estate

    Authentic and Guess? Co-Founders Maurice and Paul Marciano Complete Transaction to Take Guess? Private

    With This Landmark Deal, Authentic Now Owns 51% of Guess? IP and the Remaining 49% is Owned by the Guess? Rolling Shareholders Current Guess? Management Owns 100% of the Operating Company Authentic Brands Group (Authentic), a global brand development and licensing platform, and Guess?, Inc. (NYSE:GES) today announced they have completed the transaction to take Guess? private. Authentic now owns 51% of substantially all Guess? intellectual property, and existing Guess? shareholders, Maurice Marciano, Paul Marciano, Nicolai Marciano and Carlos Alberini and certain of their respective trusts, foundations and affiliates (collectively, the "Rolling Shareholders"), now own 49% of all Guess? i

    1/23/26 9:01:00 AM ET
    $GES
    Apparel
    Consumer Discretionary

    Guess?, Inc. Reports Fiscal Year 2026 Third Quarter Results

    Revenues Increased to $791 Million, Up 7% in U.S. Dollars and 5% in Constant Currency Delivered Operating Margin of 2.9%; Adjusted Operating Margin of 4.7% GAAP EPS of $0.48 and Adjusted EPS of $0.35 Guess?, Inc. (NYSE:GES) today reported financial results for its third quarter ended November 1, 2025. Carlos Alberini, Chief Executive Officer, commented, "We are pleased with our third quarter performance, with revenue growth of 7% in U.S. dollars and 5% in constant currency, driven by a strong performance of our Americas Wholesale and Europe businesses. In our Americas Retail business, despite continued softness, we were encouraged by the continued improvement in same store sales versus th

    11/25/25 4:15:00 PM ET
    $GES
    Apparel
    Consumer Discretionary